Quantifiable analysis of cellular pathway inhibition of a Nedd8-activating enzyme inhibitor, MLN4924, using AlphaScreen

被引:7
|
作者
Yan, Zhong-Hua [1 ]
Burkhardt, Anne [1 ]
Loke, Huay-Keng [1 ]
Chen, Jesse [1 ]
Xu, Qing [1 ]
Brauer, Pam [1 ]
Ma, Jingya [1 ]
Lin, Yafang [1 ]
Garcia, Khris [1 ]
Dick, Lawrence R. [1 ]
Bembenek, Michael E. [1 ]
机构
[1] Millennium Pharmaceut Inc, Cambridge, MA 02139 USA
关键词
MLN4924; AlphaScreen; Cell-based assay; Pathway inhibition; CANCER; ACTIVATION;
D O I
10.1016/j.ab.2013.04.016
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Cellular effects of a Nedd8-activating enzyme (NAE) inhibitor, MLN4924, using the AlphaScreen format were explored. MLN4924 acts as a substrate-assisted inhibitor of NAE by forming a tight binding Nedd8-MLN4924 adduct. The inhibited enzyme can no longer transfer Nedd8 downstream to modify and activate the E3 cullin-RING ligases. This results in the stabilization of proteins regulated by the proteasome, leading to cell death. These studies monitored the endogenous cellular changes to NAE similar to Nedd8 thioester, the formation of the Nedd8-MLN4924 adduct, and the reduction in the Cul1-Nedd8. Lysates derived from MLN4924-treated HCT116 cells showed that whereas the beta-subunit of NAE remained constant, reductions of both NAE similar to Nedd8 thioester and Cul1-Nedd8 levels occurred with a concomitant rise of the adduct. Moreover, the formation of the Nedd8-MLN4924 adduct was approximately stoichiometric with the concentration of NAE beta. Higher density 384-well cell-based assays illustrated the kinetics of enzyme inactivation across a wider range of MLN4924 concentrations, showing a rapid loss of NAE similar to Nedd8 thioester and Cul1-Nedd8. The reduction of NAE similar to Nedd8 thioester precedes the loss of Cul1-Nedd8 at twice the rate. Finally, these results clearly demonstrate the utility of the homogeneous assay for quantitative assessment of these endogenous cellular components in a 384-well plate in response to inhibition of NAE by MLN4924. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:109 / 115
页数:7
相关论文
共 50 条
  • [1] Stereoselective Synthesis of MLN4924, an Inhibitor of NEDD8-Activating Enzyme
    Lee, Hyuk Woo
    Nam, Soo Kyung
    Choi, Won Jun
    Kim, Hea Ok
    Jeong, Lak Shin
    JOURNAL OF ORGANIC CHEMISTRY, 2011, 76 (09): : 3557 - 3561
  • [2] A Gatekeeper Residue for NEDD8-Activating Enzyme Inhibition by MLN4924
    Toth, Julia I.
    Yang, Li
    Dahl, Russell
    Petroski, Matthew D.
    CELL REPORTS, 2012, 1 (04): : 309 - 316
  • [3] Quantitative Proteomic Analysis of Cellular Protein Modulation upon Inhibition of the NEDD8-Activating Enzyme by MLN4924
    Liao, Hua
    Liu, Xiaozhen J.
    Blank, Jonathan L.
    Bouck, David C.
    Bernard, Hugues
    Garcia, Khristofer
    Lightcap, Eric S.
    MOLECULAR & CELLULAR PROTEOMICS, 2011, 10 (11)
  • [4] Mechanistic RBC Partitioning Studies of MLN4924, a Nedd8-Activating Enzyme inhibitor
    Xia, Cindy Q.
    Chen, Susan
    Zhang, Ji
    Wu, Jing-Tao
    Qian, Mark G.
    Lee, Frank W.
    Balani, Suresh K.
    DRUG METABOLISM REVIEWS, 2010, 42 : 94 - 95
  • [5] The NEDD8-activating enzyme inhibitor MLN4924 reduces ischemic brain injury in mice
    Yu, Huilin
    Luo, Haiyu
    Chang, Luping
    Wang, Shisheng
    Geng, Xue
    Kang, Lijing
    Zhong, Yi
    Cao, Yongliang
    Wang, Ranran
    Yang, Xing
    Zhu, Yuanbo
    Shi, Mei-Juan
    Hu, Yue
    Liu, Zhongwang
    Yin, Xuhui
    Ran, Yunwei
    Yang, Hao
    Fan, Wenying
    Zhao, Bing-Qiao
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022, 119 (06)
  • [6] Radiosensitization of Human Colorectal Cancer Cells by MLN4924: An Inhibitor of NEDD8-Activating Enzyme
    Wan, Juefeng
    Zhu, Ji
    Li, Guichao
    Zhang, Zhen
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2016, 15 (04) : 527 - 534
  • [7] Discovery of the Nedd8 activating enzyme inhibitor MLN4924
    Langston, Steven P.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [8] Targeting the protein ubiquitination machinery in melanoma by the NEDD8-activating enzyme inhibitor pevonedistat (MLN4924)
    Wong, Kit Man
    Micel, Lindsey N.
    Selby, Heather M.
    Tan, Aik Choon
    Pitts, Todd M.
    Bagby, Stacey M.
    Spreafico, Anna
    Klauck, Peter J.
    Blakemore, Stephen J.
    Smith, Peter F.
    McDonald, Alice
    Berger, Allison
    Tentler, John J.
    Eckhardt, S. Gail
    INVESTIGATIONAL NEW DRUGS, 2017, 35 (01) : 11 - 25
  • [9] The NEDD8-Activating Enzyme Inhibitor MLN4924 Disrupts Nucleotide Metabolism and Augments the Efficacy of Cytarabine
    Nawrocki, Steffan T.
    Kelly, Kevin R.
    Smith, Peter G.
    Keaton, Mignon
    Carraway, Hetty
    Sekeres, Mikkael A.
    Maciejewski, Jaroslaw P.
    Carew, Jennifer S.
    CLINICAL CANCER RESEARCH, 2015, 21 (02) : 439 - 447
  • [10] Targeting the protein ubiquitination machinery in melanoma by the NEDD8-activating enzyme inhibitor pevonedistat (MLN4924)
    Kit Man Wong
    Lindsey N. Micel
    Heather M. Selby
    Aik Choon Tan
    Todd M. Pitts
    Stacey M. Bagby
    Anna Spreafico
    Peter J. Klauck
    Stephen J. Blakemore
    Peter F. Smith
    Alice McDonald
    Allison Berger
    John J. Tentler
    S. Gail Eckhardt
    Investigational New Drugs, 2017, 35 : 11 - 25